✦ The News Desk
The full firehose — every desk, every dispatch, in chronological order. Last filed 3h ago.
Audiologists managing patients with NF2-related schwannomatosis should be aware that targeted therapies (e.g., bevacizumab, MEK inhibitors) may stabilize or improve hearing in some patients, but evidence remains heterogeneous; coordinate with neuro-oncology for individualized...
✦ Search
✦ Filter